Ascendis Pharma A (ASND) Free Cash Flow Growth (1y) (2013 - 2026)
Ascendis Pharma A (ASND) Free Cash Flow Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
88.70% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
66.37% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ascendis Pharma A |
2.75 Bn |
2.08 Bn |
268.20 Mn |
39.96% |
| Date | Value |
|---|
| Mar 31, 2026 |
39.96% |
| Dec 31, 2025 |
-32.79% |
| Sep 30, 2025 |
104.12% |
| Jun 30, 2025 |
87.34% |
| Mar 31, 2025 |
86.33% |
| Dec 31, 2024 |
-103.56% |
| Sep 30, 2024 |
54.62% |
| Jun 30, 2024 |
60.51% |
| Mar 31, 2024 |
29.70% |
| Dec 31, 2023 |
67.23% |
| Sep 30, 2023 |
-39.65% |
| Jun 30, 2023 |
-29.13% |
| Mar 31, 2023 |
-9.94% |
| Dec 31, 2022 |
27.31% |
| Sep 30, 2022 |
5.13% |
| Jun 30, 2022 |
4.21% |
| Mar 31, 2022 |
-52.25% |
| Dec 31, 2021 |
-27.16% |
| Sep 30, 2021 |
-64.40% |
| Jun 30, 2021 |
-134.57% |
